Veterinary Medicines

Fevaxyn Pentofel (--) - Suspension for injection

Not authorised
  • Feline leukemia virus, Strain AH 927/1161E, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Download as PDF

Product identification

Medicine name:
Fevaxyn Pentofel (--) - Suspension for injection
Active substance:
  • Feline leukemia virus, Strain AH 927/1161E, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
Target species:
This information is not available for this product.
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline leukemia virus, Strain AH 927/1161E, Inactivated
    Presentation_strength:≥ 1.45 RP Reference:Hse Index:0
  • Felid herpesvirus 1, strain 605, Inactivated
    1.60
    relative potency
    /
    1.00
    Syringe
  • Feline calicivirus, strain 255, Inactivated
    1.65
    relative potency
    /
    1.00
    Syringe
  • Chlamydia felis, strain Cello, Inactivated
    2.00
    relative potency
    /
    1.00
    Syringe
  • Feline panleucopenia virus, strain CU4, Inactivated
    9.50
    relative potency
    /
    1.00
    Syringe
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Zoetis Belgium SA
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 24/10/2024
Download
Bulgarian (PDF)
Published on: 24/10/2024
Download
Croatian (PDF)
Published on: 24/10/2024
Download
Czech (PDF)
Published on: 24/10/2024
Download
Danish (PDF)
Published on: 24/10/2024
Download
Dutch (PDF)
Published on: 24/10/2024
Download
Estonian (PDF)
Published on: 24/10/2024
Download
Finnish (PDF)
Published on: 24/10/2024
Download
French (PDF)
Published on: 24/10/2024
Download
German (PDF)
Published on: 24/10/2024
Download
Greek (PDF)
Published on: 24/10/2024
Download
Hungarian (PDF)
Published on: 24/10/2024
Download
Icelandic (PDF)
Published on: 24/10/2024
Download
Italian (PDF)
Published on: 24/10/2024
Download
Latvian (PDF)
Published on: 24/10/2024
Download
Lithuanian (PDF)
Published on: 24/10/2024
Download
Maltese (PDF)
Published on: 24/10/2024
Download
Norwegian (PDF)
Published on: 24/10/2024
Download
Polish (PDF)
Published on: 24/10/2024
Download
Portuguese (PDF)
Published on: 24/10/2024
Download
Romanian (PDF)
Published on: 24/10/2024
Download
Slovak (PDF)
Published on: 24/10/2024
Download
Slovenian (PDF)
Published on: 24/10/2024
Download
Spanish (PDF)
Published on: 24/10/2024
Download
Swedish (PDF)
Published on: 24/10/2024
Download

ema-puar-v30-fevaxynpentofel-wpar-2024-10-04-en.pdf

English (PDF)
Published on: 24/10/2024
Download

ema-puar-fevaxyn-pentofel-v-030-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."